UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-01, Vol.32 (1), p.23-33

2021

Volltextzugriff (PDF)

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

Leukemia, 2018-01, Vol.32 (1), p.83-91

2018

Volltextzugriff (PDF)

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

Leukemia, 2012-07, Vol.26 (7), p.1458-1461

2012

Volltextzugriff (PDF)

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Leukemia, 2013-01, Vol.27 (1), p.142-149

2013

Volltextzugriff (PDF)

Genetic profiling of CLL: a 'TP53 addict' perspective

Cell death & disease, 2016-01, Vol.7 (1), p.e2042-e2042

2016

Volltextzugriff (PDF)

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study

Blood cancer journal (New York), 2017-02, Vol.7 (2), p.e524-e524

2017

Volltextzugriff (PDF)

Progressive clinical case-based multiple-choice questions: An innovative way to evaluate and rank undergraduate medical students

La revue de medecine interne, 2021-05, Vol.42 (5), p.302-309

2021

Volltextzugriff (PDF)

AN IMPROVED BENEFIT‐RISK PROFILE OF DUVELISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WHO RECEIVED 2 OR MORE PRIOR THERAPIES

Hematological oncology, 2019-06, Vol.37 (S2), p.213-214

2019

Volltextzugriff (PDF)

EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL

Hematological oncology, 2019-06, Vol.37 (S2), p.214-216

2019

Volltextzugriff (PDF)

Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma

Haematologica (Roma), 2010-11, Vol.95 (11), p.1865-1872

2010

Volltextzugriff (PDF)

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT‐NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR FOLLOW‐UP OF ELEVATE‐TN

HemaSphere, 2022-06, Vol.6, p.564-565

2022

Volltextzugriff (PDF)

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics

Haematologica (Roma), 2018-12, Vol.103 (12), p.1956-1968

2018

Volltextzugriff (PDF)

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

The New England journal of medicine, 2014-07, Vol.371 (3), p.213-223

2014

Volltextzugriff (PDF)

miR-34b miR-34c: a regulator of TCL1 expression in 11q− chronic lymphocytic leukaemia?

Leukemia, 2009-11, Vol.23 (11), p.2174-2177

2009

Volltextzugriff (PDF)

Computerized ranking test in three French universities: Staff experience and students' feedback

La revue de medecine interne, 2016-03, Vol.37 (3), p.166-172

2016

Volltextzugriff (PDF)

Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study

Journal of thrombosis and haemostasis, 2007-02, Vol.5 (2), p.244-249

2007

Volltextzugriff (PDF)

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Leukemia, 2016-04, Vol.30 (4), p.929-936

2016

Volltextzugriff (PDF)

Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes

Leukemia, 2005-11, Vol.19 (11), p.2002-2005

2005

Volltextzugriff (PDF)

Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL

Leukemia, 2003-01, Vol.17 (1), p.133-137

2003

Volltextzugriff (PDF)

Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100TM

International journal of laboratory hematology, 2010-12, Vol.32 (6p1), p.e237-e243

2010

Volltextzugriff (PDF)

Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia

Leukemia, 2003-12, Vol.17 (12), p.2435-2443

2003

Volltextzugriff (PDF)

5.37 Myelodysplastic Syndrome and Acute Myeloid Leukemia Following Fludarabine plus Cyclophosphamide plus Rituximab in Patients with CLL

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S268-S269

2011

Volltextzugriff (PDF)

TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes

International journal of cancer, 2016-10, Vol.139 (8), p.1759-1763

2016

Volltextzugriff (PDF)

Abrupt oxygen decrease influences thrombosis and bleeding in stenosed and endothelium-injured rabbit carotid arteries

European journal of anaesthesiology, 2008-12, Vol.25 (12), p.1002-1008

2008

Volltextzugriff (PDF)

Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway

Blood, 2004-01, Vol.103 (2), p.679-688

2004

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(110)
Tagungsberichte
(1)

Sprache

Englisch
(86)
Französisch
(25)

Erscheinungsjahr

n.n

Thema

Humans
(57)
Life Sciences & Biomedicine
(54)
Science & Technology
(54)
Hematology
(43)
Female
(32)
Male
(30)
Biological And Medical Sciences
(28)
Middle Aged
(28)
Medical Sciences
(26)
Aged
(23)
Adult
(21)
Oncology
(21)
Hematologic And Hematopoietic Diseases
(19)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(19)
Chronic Lymphocytic Leukemia
(18)
Life Sciences
(18)
Leukemia
(17)
Prognosis
(14)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(13)
Apoptosis
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Genetic profiling of CLL: a 'TP53 addict' perspective

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study

Progressive clinical case-based multiple-choice questions: An innovative way to evaluate and rank undergraduate medical students

AN IMPROVED BENEFIT‐RISK PROFILE OF DUVELISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WHO RECEIVED 2 OR MORE PRIOR THERAPIES

EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL

Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT‐NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR FOLLOW‐UP OF ELEVATE‐TN

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

miR-34b miR-34c: a regulator of TCL1 expression in 11q− chronic lymphocytic leukaemia?

Computerized ranking test in three French universities: Staff experience and students' feedback

Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes

Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL

Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100TM

Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia

5.37 Myelodysplastic Syndrome and Acute Myeloid Leukemia Following Fludarabine plus Cyclophosphamide plus Rituximab in Patients with CLL

TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes

Abrupt oxygen decrease influences thrombosis and bleeding in stenosed and endothelium-injured rabbit carotid arteries

Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway

Suchergebnisse filtern